Gut Microbiome Correlates of Response and Toxicity Following Anti-CD19 CAR T Cell Therapy
Last Updated: Friday, July 17, 2026
Investigators explored the role of the intestinal microbiome on outcomes in a multicenter study and concluded that changes in the intestinal microbiome are associated with clinical outcomes after anti-CD19 CAR T cell therapy in patients with B-cell malignancies.
Advertisement
News & Literature Highlights
